全球肿瘤学界的目光正聚焦于美国芝加哥。一年一度的美国临床肿瘤学会(ASCO)年会,不仅是肿瘤药物研发的展示窗口,更是一场无声的“军备竞赛”。在这场全球顶级学术盛会上,肺癌领域尤为引人注目,各大企业纷纷展示各自的最新突破与研究实力,从晚期到早期、新靶点到联合机制,带来上百篇摘要,口头报告近20篇。而走在全球肺癌药物研发前列的阿斯利康,更是在ASCO大秀肌肉,带来多项肺癌领域的新研究,其中SACHI、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.